ARTICLE

FindCenter AddIcon

The Worldview-Changing Drugs Poised to Go Mainstream

By Ed Prideaux — 2021

The growing legitimacy of psychedelics as therapies promises to transform how we view the extraordinary, writes Ed Prideaux.

Read on www.bbc.com

FindCenter Post-Image

Roland Griffiths: 5 Fast Facts You Need to Know

Roland Griffiths is a Johns Hopkins University professor, researcher and expert in the field of pharmacology. He is best known for his research into the beneficial effects psilocybin on cancer patients.

Article
Alyssa Choiniere
2019
FindCenter AddIcon
FindCenter Post-Image

Psilocybin Studies and the Religious Experience: An Interview with Roland Griffiths, Ph.D.

We spoke about his research with psilocybin, his interest in spiritual experiences, and how psychedelics may provide help for people who are dying.

Article
David Jay Brown with Louise Reitman
FindCenter AddIcon
FindCenter Post-Image

DMT Models the Near-Death Experience

Near-death experiences (NDEs) are complex subjective experiences, which have been previously associated with the psychedelic experience and more specifically with the experience induced by the potent serotonergic, N,N-Dimethyltryptamine (DMT).

Article
Christopher Timmermann, Leor Roseman, Luke Williams, David Erritzoe, Charlotte Martial, Héléna Cassol, Steven Laureys, David Nutt and Robin Carhart-Harris
2018
FindCenter AddIcon
FindCenter Post-Image

For the First Time, Scientists Have Imaged the Brain on LSD

The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.

Article
Victoria Turk
2016
FindCenter AddIcon
FindCenter Post-Image

Scientists Gave Depressed Patients Psilocybin in a First for Psychedelic Therapy

In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.

Article
Victoria Turk
2016
FindCenter AddIcon
FindCenter Post-Image

We Can No Longer Ignore the Potential of Psychedelic Drugs to Treat Depression

At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.

Article
Robin Carhart-Harris
2020
FindCenter AddIcon
FindCenter Post-Image

Magic Mushrooms Expand the Mind by Dampening Brain Activity

A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.

Article
Maia Szalavitz
2012
FindCenter AddIcon
FindCenter Post-Image

The Future of Psychedelic Medicine

This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.

Article
Amanda Feilding
2017
FindCenter AddIcon
FindCenter Post-Image

Interview with Albert Hofmann, the Man Who First Synthesized LSD

The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.

Article
High Times
2020
FindCenter AddIcon

EXPLORE TOPIC

Altered States of Consciousness